Influence
October 29, 2024

FDA approves Cologuard Plus™ test; Regenstrief researcher principal investigator for related study

Thomas Imperiale

Regenstrief Institute Research Scientist Thomas Imperiale, M.D., served as the principal investigator for Exact Sciences’ BLUE-C study, which led to the recent U.S. Food and Drug Administration (FDA) approval of the Cologuard Plus™ test.  

This next-generation, noninvasive colorectal cancer screening test from Exact Sciences is approved for adults 45 and older at average risk for colorectal cancer. The Cologuard Plus test demonstrated high sensitivity in detecting colorectal cancer and advanced precancerous lesions, offering a critical tool for early detection and prevention. 

The BLUE-C study, one of the largest prospective studies of its kind, included nearly 19,000 participants. The results showed that the Cologuard Plus test significantly outperformed a fecal immunochemical test (FIT) in terms of cancer sensitivity, particularly in detecting treatable-stage colorectal cancer. Dr. Imperiale emphasized that this new test, with its low false-positive rate, provides a strong option for first-line screening, helping to identify cancer early when it is most treatable. 

Thomas F. Imperiale, M.D.  

In addition to his role as a research scientist at Regenstrief Institute, Thomas F. Imperiale, M.D., is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. He is the Lawrence Lumeng Professor of Gastroenterology and Hepatology at Indiana University School of Medicine. 

Related News

Regenstrief researchers share innovations in health services at AcademyHealth 2025

Regenstrief researchers share innovations in health services at AcademyHealth 2025

Regenstrief Institute faculty and staff played a prominent role at the 2025 AcademyHealth Annual Research Meeting (ARM) June 7-10

Susan Hickman

Regenstrief and IU leader to depart for Kaiser Permanente

After serving in prominent roles at Regenstrief Institute, Indiana University School of Nursing and the IU School of Medicine,

Addressing social isolation, access to healthcare and well-being

Successful health system, congregation collaboration associated with reduced loneliness and fewer emergency department visits An innovative partnership between a

Research scientist reflects on foundational years of the AMPATH research program

On June 9 during a presentation at Indiana University’s Mini-University in Bloomington, Regenstrief Institute Research Scientist William M. Tierney,